Lasry Marc’s Orchestra BioMed OBIO Stock Holding History

Lasry Marc’s Portfolio OBIO Stock Details OBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$151K	Hold	60,869	–	–	1%	8
2025 Q2	$163K	Hold	60,869	–	–	0.91%	6
2025 Q1	$261K	Hold	60,869	–	–	1.2%	6
2024 Q4	$243K	Hold	60,869	–	–	1.08%	8
2024 Q3	$313K	Hold	60,869	–	–	0.57%	6
2024 Q2	$496K	Hold	60,869	–	–	0.49%	7
2024 Q1	$321K	Hold	60,869	–	–	0.27%	9
2023 Q4	$556K	Hold	60,869	–	–	0.82%	8
2023 Q3	$531K	Hold	60,869	–	–	0.52%	9
2023 Q2	$426K	Buy	+60,869	New	+$923K	0.55%	10

Other funds holding OBIO

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Lasry Marc's OBIO Position: Q3 2025 in Review

Lasry Marc held its Orchestra BioMed (OBIO) position steady in Q3 2025 at 60,869 shares worth $151K. The position accounts for 1% of the portfolio, ranked #8.

Lasry Marc first reported a position in OBIO in Q2 2023 and has held it in 10 quarters since. The position peaked at $556K in Q4 2023. 52 funds tracked by Wall St. Rank hold OBIO as of Q3 2025.

Lasry Marc held 60,869 shares of Orchestra BioMed worth $151K as of Q3 2025.
Lasry Marc left its Orchestra BioMed share count unchanged in Q3 2025.
Orchestra BioMed made up 1% of Lasry Marc's portfolio in Q3 2025, its #8 holding.
Lasry Marc first reported a position in Orchestra BioMed in Q2 2023 and has held it in 10 quarters since.
Lasry Marc's Orchestra BioMed position peaked at $556K in Q4 2023.
52 funds tracked by Wall St. Rank held Orchestra BioMed as of Q3 2025.

Based on Lasry Marc's 13F filing for Q3 2025, filed 14 Nov 2025.